Skip to content

Avantor

US · AVTR #1438 by market cap Listed 2019
14.84 -0.28 -1.85%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Valuation each multiple against its own 5-year range

P/B ratio 1.80 Cheap vs history 29th percentile
5-year average 2.95 · #17 of 51 in Medical Instruments & Supplies
P/E ratio 31.08 In line with history 54th percentile
5-year average 20.13 · forward 24.00 · #15 of 27 in Medical Instruments & Supplies
P/S ratio 1.59 Cheap vs history 30th percentile
5-year average 1.92 · forward 1.55 · #15 of 51 in Medical Instruments & Supplies

Vs. peers Medical Instruments & Supplies

Company Market cap P/E (TTM) P/B Div yield
Avantor (AVTR) 10.06B 29.68 1.72 0.00%
Intuitive Surgical (ISRG) 138.33B 48.25 8.65 0.00%
Becton Dickinson & Co (BDX) 57.96B 52.02 2.35 1.97%
Alcon (ALC) 35.92B 54.24 1.64 0.48%
ResMed (RMD) 33.14B 21.46 5.57 1.04%
Medline (MDLN) 32.55B 57.52 2.76 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value17.26 Economic moatNone UncertaintyMedium

Trading 16.3% below Morningstar's fair value estimate.

Fair value

Avantor Inc receives a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 10% discount to our quantitative fair value estimate of $17.26 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The firm's liquidity bolsters our estimated fair value. Adequate liquidity allows a company to meet short-term obligations, enhancing financial stability and reducing distress risk. Reflecting the firm's liquidity is its median trading volume over the past 60 days, which lies in the top 10% compared with peers globally. Trading volumes are high on shares, which may indicate increased institutional interest in stock ownership. We believe this is a sign that shares could be cheap.

On a different note, the firm's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, ranks in the bottom 30% compared with global peers. This could imply a planned dividend cut or relatively high share price, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance bodes well for future returns in light of other contributors to our model.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Avantor discussion 0 comments

Add a comment